Skip to main content

Table 11 Summaries of plasma amyloid-β 1–42 peptide assay measured from quality control samples (QC1 and QC3) during clinical sample analysis

From: A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics

 

Measured Aβ1–42 (pg/ml)

 

Run 1

Run 2

Run 3

Expected range of Aβ1–42 (pg/ml)a

QC1

21.6

21.4

19.4

20 ± 2

QC3

0.748

0.681

0.642

0.689 ± 0.069

  1. Aβ amyloid-β, QC Quality control
  2. aExpected range was within ±10% of the averaged Aβ1–42 concentration measured from precision study
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193